Nephron Research Cuts Walgreens Boots Alliance's Price Target to $13 From $24, Hold Rating Maintained
Nephron Research Cuts Walgreens Boots Alliance's Price Target to $13 From $24, Hold Rating Maintained
Nephron研究将沃尔格林-联合博姿的目标价格从24美元下调至13美元，维持持有评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册